Abstract
Purpose of Review
Pancreatic cancer continues to be a disease associated with poor long-term survival. Surgical resection is associated with high morbidity and delays in systemic therapy.
Recent Findings
Recognition of pancreatic cancer as a systemic disease has led to the increased utilization of multimodality therapy and shifting paradigms in the sequence of care. Identification of biomarkers and improved understanding of tumor biology have allowed for improved patient stratification and an individualized approach to treatment planning. Additionally, introduction of minimally invasive approaches to pancreatic resection have improved rates of significant post-operative morbidity.
Summary
Cumulatively, these new developments have altered the approach to surgical resection and aid in improving patient survival.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/25MOrgB
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου